Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 106783
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106783
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106783
Figure 3 Network pharmacological analysis of potential targeted signaling pathways of Qige San in esophageal cancer.
A: Active compounds and target genes identified by Traditional Chinese Medicine Systems Pharmacology database; B: Overlapped genes of disease targets from GeneCards, Therapeutic Target Database, and Online Mendelian Inheritance in Man database; C: Overlapped genes of disease targets and drug targets; D: Gene Ontology analysis of the overlapped genes; E: Kyoto Encyclopedia of Genes and Genomes analysis of the overlapped genes; F: HALLMARK analysis of the overlapped genes; G: REACTOME analysis of the overlapped genes; H: Protein-protein interaction analysis of the overlapped genes; I: Gene Ontology analysis of the connected genes; J: Kyoto Encyclopedia of Genes and Genomes analysis of the connected genes; K: HALLMARK analysis of the connected genes; L: REACTOME analysis of the connected genes.
- Citation: Song J, Guo WY, Sun LB. Qige San regulates paclitaxel resistance in esophageal cancer by targeting ferroptosis. World J Gastrointest Oncol 2025; 17(8): 106783
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/106783.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.106783